Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marisol S Castaneto

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Journal of Forensic Sciences|September 13, 2022
Impact of cannabis-infused edibles on public safety and regulationAlain Peralt, Pucheng Ke, Marisol S Castaneto
Biomedical Chromatography : BMC|May 17, 2020
Assessment of synthetic cannabinoid FUB-AMB and its ester hydrolysis metabolite in human liver microsomes and human blood samples using UHPLC-MS/MSBrandon C Presley, Marisol S Castaneto, Barry K Logan, et al.
Therapeutic Drug Monitoring|March 31, 2022
Evaluation of a Highly Efficient Multidrug Biochip Array Technology for a Simultaneous and High-Throughput Urine Drug Screening in Clinical and Toxicological SettingsMarisol S Castaneto, Chihyon Huang, Duriza Capps, et al.
Rapid Communications in Mass Spectrometry : RCM|July 26, 2020
Metabolic profiling of synthetic cannabinoid 5F-ADB and identification of metabolites in authentic human blood samples via human liver microsome incubation and ultra-high-performance liquid chromatography/high-resolution mass spectrometryBrandon C Presley, Marisol S Castaneto, Barry K Logan, et al.
Therapeutic Drug Monitoring|May 21, 2015
Urine Mescaline Screening With a Biochip Array Immunoassay and Quantification by Gas Chromatography-Mass SpectrometryDilek Battal, Allan J Barnes, Marisol S Castaneto, et al.
Drug Testing and Analysis|September 9, 2018
Can synthetic urine replace authentic urine to "beat" workplace drug testing?Victor J Kim, Catherine K Okano, Caroline R Osborne, et al.
Drug and Alcohol Dependence|September 16, 2014
Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implicationsMarisol S Castaneto, David A Gorelick, Nathalie A Desrosiers, et al.
The AAPS Journal|February 28, 2015
Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACAAriane Wohlfarth, Marisol S Castaneto, Mingshe Zhu, et al.
Drug Metabolism Reviews|April 9, 2015
Synthetic cannabinoids pharmacokinetics and detection methods in biological matricesMarisol S Castaneto, Ariane Wohlfarth, Nathalie A Desrosiers, et al.
Analytical and Bioanalytical Chemistry|April 24, 2015
Biochip array technology immunoassay performance and quantitative confirmation of designer piperazines for urine workplace drug testingMarisol S Castaneto, Allan J Barnes, Marta Concheiro, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Journal of Forensic Sciences|September 13, 2022
Impact of cannabis-infused edibles on public safety and regulationAlain Peralt, Pucheng Ke, Marisol S Castaneto
Biomedical Chromatography : BMC|May 17, 2020
Assessment of synthetic cannabinoid FUB-AMB and its ester hydrolysis metabolite in human liver microsomes and human blood samples using UHPLC-MS/MSBrandon C Presley, Marisol S Castaneto, Barry K Logan, et al.
Therapeutic Drug Monitoring|March 31, 2022
Evaluation of a Highly Efficient Multidrug Biochip Array Technology for a Simultaneous and High-Throughput Urine Drug Screening in Clinical and Toxicological SettingsMarisol S Castaneto, Chihyon Huang, Duriza Capps, et al.
Rapid Communications in Mass Spectrometry : RCM|July 26, 2020
Metabolic profiling of synthetic cannabinoid 5F-ADB and identification of metabolites in authentic human blood samples via human liver microsome incubation and ultra-high-performance liquid chromatography/high-resolution mass spectrometryBrandon C Presley, Marisol S Castaneto, Barry K Logan, et al.
Therapeutic Drug Monitoring|May 21, 2015
Urine Mescaline Screening With a Biochip Array Immunoassay and Quantification by Gas Chromatography-Mass SpectrometryDilek Battal, Allan J Barnes, Marisol S Castaneto, et al.
Drug Testing and Analysis|September 9, 2018
Can synthetic urine replace authentic urine to "beat" workplace drug testing?Victor J Kim, Catherine K Okano, Caroline R Osborne, et al.
Drug and Alcohol Dependence|September 16, 2014
Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implicationsMarisol S Castaneto, David A Gorelick, Nathalie A Desrosiers, et al.
The AAPS Journal|February 28, 2015
Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACAAriane Wohlfarth, Marisol S Castaneto, Mingshe Zhu, et al.
Drug Metabolism Reviews|April 9, 2015
Synthetic cannabinoids pharmacokinetics and detection methods in biological matricesMarisol S Castaneto, Ariane Wohlfarth, Nathalie A Desrosiers, et al.
Analytical and Bioanalytical Chemistry|April 24, 2015
Biochip array technology immunoassay performance and quantitative confirmation of designer piperazines for urine workplace drug testingMarisol S Castaneto, Allan J Barnes, Marta Concheiro, et al.
Pageof 3